18 March 2020

On Friday 12 June NWO will organise the 2020 edition of Bessensap! Around 350 journalists, press officers and researchers will meet to exchange knowledge on the latest developments in science and communication and network with colleagues. This is your chance to showcase your research story. 

NWO is looking for researchers who are interested in presenting their research to a large audience of science journalists and communicators. They challenge researchers at all levels to submit a proposal: NWO is just as open to talented young researchers as to those with a long record of scientific achievement. Presentations of research that is not being funded by NWO are also more than welcome.

Register your proposal before Wednesday 10 April 2020 (extended deadline).

More information (only in Dutch and Z-number needed): link.

Related news items


Dutch Cancer Society Grant received by Annemiek van Spriel and Laia Querol-Cano

23 September 2020

Annemiek van Spriel and Laia Querol-Cano received a Dutch Cancer Society Grant of 707,298 euros to study the cancer cell surface in immunotherapy.

read more

Frank Walboomers 25-years work anniversary at Radboudumc

17 September 2020

Frank Walboomers, associate professor at the research group Regenerative Biomaterials at the Dept. of Dentistry (theme Reconstructive & Regenerative Medicine), celebrated his 25th work anniversary at Radboudumc.

read more

Tjitske Kleefstra appointed endowed professor of Clinical genetics and psychopathology of rare syndromes

17 September 2020

Tjitske Kleefstra has been appointed endowed professor of Clinical genetics and psychopathology of rare syndromes at the department of Neurodevelopmental disorders, with effect from 1 September.

read more

Annette Schenck appointed professor of Translational Genetics

17 September 2020

Annette Schenck has been appointed professor of Translational Genetics at the department of Neurodevelopmental disorders, with effect from 1 August. The chair will bring together fundamental and translational research in the field of brain developmental disorders.

read more

Centuries-old medicine reduces the risk of new cardiovascular disease in heart patients

17 September 2020

Colchicine, an anti-inflammatory drug that has been used for gout for centuries, has been shown to prevent cardiovascular disease in patients who have had a heart attack or are suffering from narrowed coronary arteries. Results of the study are published in the New England Journal of Medicine.

read more